Context Therapeutics Inc. · NASDAQ:CNTX

Octagon Capital Advisors LP reported a 5.70% stake in Context Therapeutics Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 14, 2026

Octagon Capital Advisors LP reported a 5.70% stake in Context Therapeutics Inc., 5,250,000 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G).

Stake
5.70%
Shares
5,250,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP5.70%5,250,000
Octagon Investments Master Fund LP5.70%5,250,000
Ting Jia5.70%5,250,000

Source

View original at SEC

Related